Oculis and EURETINA Announce the Winner of the Inaugural Ramin Tadayoni Award
ZUG, Switzerland, Sept. 19, 2024 ( GLOBE NEWSWIRE ) -- Oculis Holding AG ( Nasdaq: OCS ) ( "Oculis" ) , a global biopharmaceutical company purposefully driven to save sight and improve eye care, in collaboration with EURETINA, today announced the winner of the Inaugural Ramin Tadayoni Award.
Ticker |
Sentiment |
Impact |
AON
|
Neutral
|
7 %
|
OCS
|
Bullish
|
43 %
|